CLINICAL_TRIALS
trial_result
· 2016-10-27
Clinical Trial Update: Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP) [Phase 2]
Summary
A Phase 2 study evaluated whether adding exposure and response prevention to ketamine could extend its effects for obsessive-compulsive disorder, with results p…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Obsessive-Compulsive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2016-10-27